RxDoctor Payments Data

Sarah White

Medical · San Antonio, TXNPI 1053638304

Payments from drug & device makers

$11,898in general payments, 2019–2025

Across 590 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novartis$1K
  • Pfizer$1K
  • UCB, Inc.$993
  • Johnson & Johnson$958
  • Mallinckrodt Hospital Products Inc.$941
  • plus $4K from 29 others

What the payments were for

  • Food & beverage$11,843100%
  • Education$550%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,898 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept34$260,122
Orencia ClickjectAbatacept13$115,385
RinvoqUpadacitinib14$102,223
Humira(Cf)Adalimumab14$95,361
BenlystaBelimumab12$58,410
OtezlaApremilast12$54,570
Hydroxychloroquine Sulfate156$4,559
Cevimeline Hcl14$2,893
MethotrexateMethotrexate Sodium112$2,739
Gabapentin94$1,929
Leflunomide31$1,809
Pilocarpine Hcl17$1,574
Pregabalin35$1,229
Prednisone90$1,027
Tramadol Hcl103$849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Humira(Cf)$86$197,58428 claims
GSKBenlysta$257$58,41012 claims
AmgenOtezla$2,392$54,57012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,490 medical providers in Texas.

Other medical in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →